Clinical Trial 39659

share

O'fallon, MO 63368


Study Summary:

Psychiatric Care and Research Study are conducting - 401 study and 402 study  that are looking at a potential new treatment - an investigational medication - for bipolar depression (bipolar I or bipolar II disorder) to see whether it works, and how safe it is, for improving the symptoms of bipolar depression.  The 401 Study will look at the investigational medication when it is used on its own.  The 402 Study will look at the investigational medication in patients who are already taking a mood stabilizer, specifically lithium or valproate.  

We are looking for people who are currently experiencing major depressive episodes associated with bipolar disorder to take part in the 401 and 402 Studies. 


Qualified Participants Must:

• Be between 18 and 75 years of age
• Have been diagnosed with bipolar I or bipolar II disorder
• Be currently having a major depressive episode that started at least 2 weeks ago, but no more than 6 months ago
• Have previously had a least one bipolar manic episode or mixed episode (if you have bipolar I disorder) or hypomanice episode (if you have bipolar II disorder)
• Not have substance abuse within 12 months of screening


Qualified Participants May Receive:

Compensation for time and travel may be possible.
Complete psychiatric examination.


Research Site Profile

View Clinic Profile


Study is Available At:

Psychiatric Care and Research Center
4132 Keaton Crossing BLVD, STE 201
O'fallon, MO 63368
View Clinic Location

 


If you would like to get the phone number or be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.